DISCLOSING MONETARY TERMS OF R&D ALLIANCES
DOI:
https://doi.org/10.29121/ijetmr.v11.i9.2024.1486Keywords:
R&D, Alliances, Signaling, Biotechnology, PharmaceuticalAbstract
We investigate how biotechnology and pharmaceutical R&D alliances operating in an emerging and uncertain environment affects the partner’s decisions to provide unmandated alliance monetary terms. We identify factors promoting R&D alliance partners' desire to disclose monetary arrangements, and factors compelling firms to conceal these arrangements. Voluntarily disclosed monetary arrangements of R&D alliances may impact the overall success of the alliance, partners' performance independent of the alliance, and future R&D costs. Disclosure likely lowers the future cost of capital for certain partners, reducing future R&D costs; yet, disclosure may inadvertently provide proprietary information to competitors. Biotechs seek partnership with pharmaceuticals with established track records in getting drugs to market. Pharmaceuticals seek partnerships with biotechs possessing skills, (i.e. R&D research). We contend the biotech partner's stock price uncertainty and near-term financial capital needs and the larger pharmaceutical firm's market experience will impact the decision to disclose alliance monetary arrangements. We find support for our hypotheses using Probit regressions.
Downloads
References
Aboody, D., & Lev, B. (2000). Information Asymmetry, R&D, and Insider Gains. Journal of Finance, 55(6), 2747 - 2766. https://doi.org/10.1111/0022-1082.00305
Ackerlof, G. A. (1970). The Market for 'lemons'. Quarterly Journal of Economics, 84, 488 - 500. https://doi.org/10.2307/1879431
Admati, A. R., & Pfleiderer, P. (1994). Robust Financial Contracting and the Role of Venture Capitalists. Journal of Finance, 49(2), 371 - 402. https://doi.org/10.1111/j.1540-6261.1994.tb05146.x
Admati, A. R., Pfleiderer, P., & Zechner, J. (1994). Large Shareholder Activism, Risk Sharing, and Financial Market Equilibrium. Journal of Political Economy, 102(6), 1097-1130. https://doi.org/10.1086/261965
Akgiray, V. (1989). Conditional Heteroscedasticity in Time Series of Stock Returns. Journal of Business, 62(1), 55-80. https://doi.org/10.1086/296451
Anand, B. N., & Khanna, T. (2000). Do Firms Learn to Create Value ? Strategic Management Journal, 21(3), 295-315.https://doi.org/10.1002/(SICI)1097-0266(200003)21:3<295 : AID-SMJ91>3.0.CO ;2-O
Anton, J. J., & Yao, D. A. (2002). The Sale of Ideas: Strategic Disclosure, Property Rights, and Contracting. Review of Economic Studies, 69(3), 513 - 531. https://doi.org/10.1111/1467-937X.t01-1-00020
Audretsch, D. B., & Feldman, M. P. (1996). R&D Spillovers and the Geography of Innovation and Production. American Economic Review, 86(3), 630-640.
Audretsch, D. B., & Weigand, J. (2005). Do Knowledge Conditions Make a Difference?: Investment, Finance and Ownership in German Industries. Research Policy, 34(5), 595-613. https://doi.org/10.1016/j.respol.2004.12.004
Baillie, R. T., & DeGennaro, R. P. (1990). Stock Returns and Volatility. The Journal of Financial and Quantitative Analysis, 25(2), 203 - 214. https://doi.org/10.2307/2330824
Bergh, D. D., Connelly, B. L., Ketchen Jr, D. J., & Shannon, L. M. (2014). Signalling Theory and Equilibrium in Strategic Management Research: An Assessment and a Research Agenda. Journal of management Studies, 51(8), 1334-1360. https://doi.org/10.1111/joms.12097
Bergh, D. D., Ketchen Jr, D. J., Orlandi, I., Heugens, P. P., & Boyd, B. K. (2019). Information Asymmetry in Management Research: Past Accomplishments and Future Opportunities. Journal of Management, 45(1), 122-158.https://doi.org/10.1177/0149206318798026
Bhattacharya, S. (1979). Imperfect Information, Dividend Policy, and 'The Bird in hand' Fallacy. Bell Journal of Economics, 10(1), 259- 270. https://doi.org/10.2307/3003330
Bhattacharya, S., & Ritter, J. R. (1983). Innovation and Communication : Signaling with Partial Disclosure. Review Of Economic Studies, 50, 331 - 346. https://doi.org/10.2307/2297419
Bhojraj, S., Blacconiere, W. G., & D'Souza, J. D. (2004). Voluntary Disclosure in a Multi-Audience Setting. The Accounting Review, 79(4), 921 - 947. https://doi.org/10.2308/accr.2004.79.4.921
Bollerslev, T. (1986). Generalized Autoregressive Conditional heteroscedasticity. Journal of Econometrics, 31, 307 - 327. https://doi.org/10.1016/0304-4076(86)90063-1
Botosan, C. A. (2006). Disclosure and the Cost of Capital. Accounting and Business Research, 31 - 40. https://doi.org/10.1080/00014788.2006.9730042
Businessweek. (2008). GM's crippling burn rate. Businessweek.
Choi, J., & Contractor, F. J. (2019). Improving the Progress of Research & Development (R&D) Projects by Selecting an Optimal Alliance Structure and Partner Type. British Journal of Management, 30(4), 791-809. https://doi.org/10.1111/1467-8551.12267
Dhaliwal, D. S., Li, O. Z., Tsang, A., & Yang, Y. G. (2011). Voluntary Nonfinancial Disclosure and The Cost of Equity Capital. The Accounting Review, 86(1), 59 - 100. https://doi.org/10.2308/accr.00000005
Eccles, R. G., Hertz, R. H., Keegan, M., & Phillips, D. M. H. (2001). The Value Reporting Revolution : Moving Beyond the Earnings Game. New York : Wiley.
Ferrara, J. S. (2011). Biotech vs. pharmaceutical Companies: What's the Difference? http://www.valueline.com/Tools/Educational_Articles/Stocks_Detail.aspx?id=10278
Folta, T. B., & Janney, J. J. (2004). Strategic Benefits to Firms Issuing Private Equity Placements. Strategic Management Journal, 25(3), 223-242. https://doi.org/10.1002/smj.373
Folta, T. B., & O Brien, J. P. (2004). Entry in the Presence of Dueling Options. Strategic Management Journal, 25, 121 - 138. https://doi.org/10.1002/smj.368
Frankel, R., McNichols, M., & Wilson, G. P. (1995). Discretionary Disclosure and External Financing. The Accounting Review, 70(1), 135 - 150.
Gallini, N. T., & Wright, B. D. (1990). Technology Transfer Under Asymmetric Information. RAND Journal of Economics (RAND Journal of Economics), 21(1), 147-160. https://doi.org/10.2307/2555500
Graham, J. R., Harvey, C. R., & Rajgopal, S. (2006). Value Destruction and Financial Reporting Decisions. Financial Analysts Journal, 62(6), 27-39. https://doi.org/10.2469/faj.v62.n6.4351
Guo, R.-J., Lev, B., & Zhou, N. (2004). Competitive Costs of Disclosure by Biotech IPOs. Journal of Accounting Research, 42(2), 319-335. https://doi.org/10.1111/j.1475-679X.2004.00140.x
Hall, B. H. (2005). The Financing of Innovation. In S. Shane (Ed.), Blackwell Handbook of Technology and Innovation Management. Oxford : Blackwell Publishers.
Hamilton, D. P. (2002). As Investors Flee Biotechs, Dreaded 'Burn Rate' Returns. Wall Street Journal.
Handa, P., & Linn, S. C. (1991). Equilibrium Factor Pricing with Heterogeneous Beliefs. The Journal of Financial and Quantitative Analysis, 26(1), 11 - 22. https://doi.org/10.2307/2331240
Healy, P. M., & Palepu, K. G. (2001). Information Asymmetry, Corporate Disclosure, and the Capital Markets. Journal of Accounting and Economics, 31(1-3), 405-440. https://doi.org/10.1016/S0165-4101(01)00018-0
Healy, P. M., Hutton, A. P., & Palepu, K. G. (1999). Stock Performance and Intermediation Changes sUrrounding Sustained Increases in Disclosure. Contemporary Accounting Research, 16(3), 485 - 520. https://doi.org/10.1111/j.1911-3846.1999.tb00592.x
Heitzman, S., Wasley, C., & Zimmerman, J. (2010). The Joint Effects of Materiality Thresholds and Voluntary Disclosure Incentives on Firms' Disclosure Decisions. Journal of Accounting and Economics, 49(1/2), 109 - 132. https://doi.org/10.1016/j.jacceco.2009.10.002
Henderson, R., & Cockburn, I. (1994). Measuring Competence? Exploring Firm Effects in Pharmaceutical Research. Strategic Management Journal, 15, 63 - 84. https://doi.org/10.1002/smj.4250150906
Hoang, H., & Rothaermel, F. T. (2010). Leveraging Internal and External Experience: Exploration, Exploitation, and R&D Project Performance. Strategic Management Journal, 31(7), 734-758. https://doi.org/10.1002/smj.834
Jacobs, T. (2002). Biotech Follows Dot.com Boom and Bust. Nature Biotechnology, 20(10), 973. https://doi.org/10.1038/nbt1002-973
James, S. D., & Shaver, J. M. (2016). Motivations for Voluntary Public R&D Disclosures. Academy of Management Discoveries, 2(3), 290-312. https://doi.org/10.5465/amd.2013.0006
Janney, J. J., & Folta, T. B. (2006). Moderating Effects of Investor Experience on the sIgnaling Value of Private Equity Placements. Journal of Business Venturing, 21(1), 27 - 44. https://doi.org/10.1016/j.jbusvent.2005.02.008
Lambert, R., Leuz, C., & Verrecchia, R. E. (2007). Accounting Information, Disclosure, and the Cost of Capital. Journal of Accounting Research, 385 - 420. https://doi.org/10.1111/j.1475-679X.2007.00238.x
Lang, M. H., & Lundholm, R. J. (1996). Corporate Disclosure Policy and Analyst Behavior. The Accounting Review, 71(4), 467 - 492.
Levitas, E., & Chi, T. (2010). A look at the Value Creation Effects of Patenting and Capital Investment Through a Real Options Lens. Strategic Entrepreneurship Journal, 4(212 - 233). https://doi.org/10.1002/sej.92
Levitas, E., & McFadyen, M. A. (2009). Managing Liquidity in Research-Intensive Firms. Strategic Management Journal, 30, 659 - 678. https://doi.org/10.1002/smj.762
Myers, S. C., & Majluf, N. S. (1984). Corporate Financing and Investment Decisions when Firms have Information that Investors do not have. Journal of Financial Economics, 13, 187 - 221. https://doi.org/10.1016/0304-405X(84)90023-0
Nicholson, S., Danzon, P. M., & McCullough, J. (2005). Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality. Journal of Business 78(4), 1433-1464. https://doi.org/10.1086/430865
Pisano, G. (2006). Science Business : The Promise, the Reality and the Future of Biotech. Boston : Harvard Business School Press.
Roijakkers, N., & Hagedoorn, J. (2006). Inter-Firm R&D Partnering in Pharmaceutical Biotechnology Since 1975. Research Policy, 35(3), 431-446. https://doi.org/10.1016/j.respol.2006.01.006
Ross, S. (1977). The Determination of Financial Structure. Bell Journal of Economics, 8, 23 - 40. https://doi.org/10.2307/3003485
Ryan-Charleton, T., Gnyawali, D. R., & Oliveira, N. (2022). Strategic Alliance Outcomes: Consolidation and New Directions. Academy of Management Annals, 16(2), 719-758. https://doi.org/10.5465/annals.2020.0346
Sentana, E., & Wadhwani, S. (1991). Semi-parametric Estimation and the Predictability of Stock Market Returns. The Review of Economic Studies, 58(3), 547 - 563. https://doi.org/10.2307/2298011
Simpson, A., & Tamayo, A. (2020). Real Effects of Financial Reporting and Disclosure on Innovation. Accounting and Business Research, 50(5), 401-421. https://doi.org/10.1080/00014788.2020.1770926
Skinner, D. J. (1994). Why Firms Voluntarily Disclose Bad news. Journal of Accounting Research, 32(1), 38 - 60. https://doi.org/10.2307/2491386
Spence, A. M. (1974). Market Signaling : Informational Transfer in Hiring and Related Screening Processes. Cambridge : Harvard University Press.
Stulz, R. M. (1990). Managerial Discretion and Optimal Financing Policies. Journal of Financial Economics, 26, 3 - 27. https://doi.org/10.1016/0304-405X(90)90011-N
Verrecchia, R. E. (1990). Information quality and Discretionary Disclosure. Journal of Accounting and Economics, 12(4), 365-380. https://doi.org/10.1016/0165-4101(90)90021-U
Verrecchia, R. E. (2001). Essays on Disclosure. Journal of Accounting & Economics, 32(1 - 3), 97 - 179. https://doi.org/10.1016/S0165-4101(01)00025-8
Wang, D., Wei, J., Noorderhaven, N., & Liu, Y. (2023). Signaling Effects of CSR Performance on Cross-Border Alliance Formation. Journal of Business Ethics, 1-20. https://doi.org/10.1007/s10551-023-05432-x
Yasar, B., Martin, T., & Kiessling, T. (2020). An Empirical Test of Signalling Theory. Management Research Review, 43(11), 1309-1335. https://doi.org/10.1108/MRR-08-2019-0338
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Edward Levitas, Sarthak Singh, M. Ann McFayden, Mujtaba Ahsan
This work is licensed under a Creative Commons Attribution 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere.
- That its release has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with International Journal of Engineering Technologies and Management Research agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
For More info, please visit CopyRight Section
